New Real-World study tracks fabry Drug's Long-Term impact on heart and kidneys
Disease control
Not yet recruiting
This study follows 75 adults with Fabry disease who are taking or starting pegunigalsidase alfa to see how well it works and how safe it is over time in real-world settings. Researchers will check heart structure and function, kidney health, and exercise capacity. The goal is to …
Sponsor: Chiesi Italia • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC